Clark R E, Brillman J, Davis D A, Lovell M R, Price T R, Magovern G J
Cardiovascular and Pulmonary Research Center, Allegheny-Singer Research Institute, Pittsburgh, PA 15212.
J Thorac Cardiovasc Surg. 1995 Feb;109(2):249-57; discussion 257-8. doi: 10.1016/S0022-5223(95)70386-1.
Cerebral dysfunction after coronary artery bypass operations represents some of the most serious and costly complications of cardiac surgery. We used transcranial Doppler ultrasonography to detect and quantify the number of microemboli in the right middle cerebral artery of patients undergoing elective first coronary bypass operations (n = 117) and second coronary bypass operations (n = 10). We hypothesized that total microemboli were related to clinical outcome. A 2 MHz transducer was positioned in front of the ear above the zygomatic arch and depth gated to 50 mm. Microemboli were recorded as perturbations of the blood flow velocity in the middle cerebral artery and aurally monitored. Each episode of microembolism was specified both by clock time and as a perfusion or surgical event. Forty-one patients (32%) completed neuropsychologic evaluation with a battery of tests for cognitive function. Anxiety states and traits were also assessed. The distribution of microembolism showed that there were three groups of patients: < 30 microemboli (n = 83); 30 to 59 (n = 24); and > 60 (n = 20). Seven of 10 patients with cerebral complications (stroke, coma, delirium, aberrant behavior) were in the > 60 microemboli group. Those with cerebral complications had 20.7 +/- 4.5 microemboli from perfusion and 57.4 +/- 15.6 from surgical events. The 13 patients in the > 60 microemboli group without central nervous system symptoms had 95.5 +/- 19.5 microemboli from perfusion and 36.0 +/- 6.9 from surgical events. Neuropsychologic scores were most often depressed for memory (73%), comprehension (49%), attention (46%), and constructional ability (44%). The greatest change was in total score in the > 60 microemboli group (-3.3 +/- 0.6) compared with -1.1 +/- 0.2 and -1.9 +/- 0.2 for the 30 to 59 and < 30 groups, respectively. The incidences of cardiac and pulmonary complications and mortality were different between those patients with < 60 microemboli versus those with > 60 microemboli. Cardiac and pulmonary complications and mortality percentages were 4.7%, 3.7%, and 0.9%, respectively, for the < 60 microemboli group and 20%, 20%, and 15%, respectively, for the > 60 microemboli group. We concluded that transcranial Doppler ultrasonography is a useful technique to quantify and detect the source of microemboli during coronary artery bypass operations and may be useful in assessing new operative strategies, the quality of the perfusion, and potentially as an indicator for pharmacologic therapy in the operating room in patients with high microemboli counts.
冠状动脉搭桥手术后的脑功能障碍是心脏手术中一些最严重且代价高昂的并发症。我们使用经颅多普勒超声检测并量化择期首次冠状动脉搭桥手术患者(n = 117)和二次冠状动脉搭桥手术患者(n = 10)右侧大脑中动脉的微栓子数量。我们假设微栓子总数与临床结局相关。将一个2兆赫的换能器置于颧弓上方耳前,并将深度门控设定为50毫米。微栓子被记录为大脑中动脉血流速度的扰动,并通过听觉进行监测。每次微栓塞事件都通过时钟时间以及作为灌注或手术事件来确定。41名患者(32%)通过一系列认知功能测试完成了神经心理学评估。同时也评估了焦虑状态和特质。微栓塞的分布显示有三组患者:< 30个微栓子(n = 83);30至59个(n = 24);以及> 60个(n = 20)。10例发生脑部并发症(中风、昏迷、谵妄、异常行为)的患者中有7例在微栓子> 60个的组中。发生脑部并发症的患者灌注相关微栓子有20.7 ± 4.5个,手术相关微栓子有57.4 ± 15.6个。微栓子> 60个组中13例无中枢神经系统症状的患者灌注相关微栓子有95.5 ± 19.5个,手术相关微栓子有36.0 ± 6.9个。神经心理学评分最常降低的是记忆力(73%)、理解力(49%)、注意力(46%)和构建能力(44%)。微栓子> 60个组的总分变化最大(-3.3 ± 0.6),相比之下,微栓子30至59个组和< 30个组分别为-1.1 ± 0.2和-1.9 ± 0.2。微栓子< 60个的患者与微栓子> 60个的患者在心脏和肺部并发症及死亡率方面存在差异。微栓子< 60个组的心脏和肺部并发症及死亡率百分比分别为4.7%、3.7%和0.9%,微栓子> 60个组分别为20%、20%和15%。我们得出结论,经颅多普勒超声是一种在冠状动脉搭桥手术期间量化和检测微栓子来源的有用技术,可能有助于评估新的手术策略、灌注质量,并有可能作为手术室中微栓子计数高患者药物治疗的指标。